Physician profile
Ashesh Parikh
NPI 1003080375
$15,632.52
in general payments reported to CMS, 2019-2025
38 companies · $9,794 in 2025
The $9,794 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $489 · 2021: $78.81 · 2022: $1,077 · 2023: $2,125 · 2024: $1,487 · 2025: $9,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,400 · Food and Beverage: $5,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,400.00 |
| Food and Beverage | $5,006.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $9,042.01 | 2020-2025 | |
| Medtronic, INC. | $818.24 | 2023-2025 | Linq II, Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $627.24 | 2022-2023 | Watchman Access System, Varithena Administration Pack, Rotablator Rotational Atherectomy System Console Kit |
| Merck Sharp & Dohme LLC | $602.73 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $562.38 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $512.94 | 2022-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $478.09 | 2019-2025 | Lifevest |
| Amgen INC. | $352.27 | 2019-2024 | Repatha |
| Heartflow, INC. | $301.50 | 2022-2024 | Ffrct |
| Abbott Laboratories | $295.21 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Janssen Pharmaceuticals, INC | $289.80 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $261.32 | 2019-2024 | Farxiga |
| Astellas Pharma US INC | $152.04 | 2019-2021 | |
| Irhythm Technologies, INC. | $139.21 | 2023 | Zio Xt Patch |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.41 | 2022-2025 | Jardiance |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $112.52 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $108.69 | 2019 | |
| Alnylam Pharmaceuticals INC. | $94.64 | 2022-2023 | Onpattro |
| Kestra Medical Technology Services, INC. | $90.18 | 2025 | Assure Wcd |
| Novo Nordisk INC | $70.95 | 2024-2025 | Ozempic |
| Davol INC. | $69.39 | 2024-2025 | Arista, Arista Ah Flexitip |
| Abiomed | $57.46 | 2020-2025 | |
| Philips North America LLC | $56.50 | 2020-2023 | |
| Cvrx, INC. | $52.33 | 2024 | Barostim Neo System |
| Atricure, INC. | $52.27 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $34.00 | 2019-2024 | |
| Amarin Pharma, INC. | $30.91 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $29.43 | 2023 | Arcalyst |
| Recor Medical INC | $29.17 | 2025 | Paradise Ultrasound Renal Denervation System |
| Becton, Dickinson and Company | $25.86 | 2024 | Rotarexs 6 F X 135 Cm |
| Itamar Medical INC | $23.13 | 2023 | Watchpatone |
| Medicomp INC | $21.06 | 2024 | Telepatch Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $19.37 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $19.22 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $18.95 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.95 | 2019 | |
| Integra Lifesciences Corporation | $14.07 | 2024 | Biofix, Biodfactor, Biodoptix |
| Arbor Pharmaceuticals, INC. | $12.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashesh Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.